Medtronic’s defibrillation lead gains FDA approval for use in right ventricle
The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ventricular. The post Medtronic’s defibrillation lead gains FDA approval for use in right ventricle appeared first on Medical Device Network.

The post Medtronic’s defibrillation lead gains FDA approval for use in right ventricle appeared first on Medical Device Network.